Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Datamonitors' KineMed, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by KineMed, Inc. since January 2007.
– Provides intelligence on KineMed, Inc.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions. – Detailed reports of various financial transactions undertaken by KineMed, Inc. and its subsidiaries since 2007. – Information about key financial and legal advisors for KineMed, Inc.'s financial deals transactions. – Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
This report includes KineMed, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by KineMed, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Reasons to Purchase:
– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. – Form an independent opinion about KineMed, Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007. – Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
The US healthcare industry’s transition to a patient-centric model is moving rapidly with focus on outcomes and value; however, drug prices have increased and pharmaceutical research and development (R&D) productivity is at its lowest. The healthcare industry and IT solutions providers are finding real-world evidence (RWE) as a potential solution...
Biopreservation refers to the process of preserving cells, tissues or organs outside of their native environment for extended period of time. It has emerged as an effective preservation technique for long-term storage. Owing to this, biopreservation has become vital for the success of various clinical and commercial...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
120 pages •
By Infiniti Research Limited
• Dec 2020
Global Gel Electrophoresis Market 2020-2024
The analyst has been monitoring the gel electrophoresis market and it is poised to grow by $ 381.92 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. Our report on gel electrophoresis market provides a holistic analysis, market size and forecast, trends,...
The Asia Pacific medical writing market is expected to reach US$ 983.51 million by 2027 from US$ 560.59 million in 2019; it is anticipated to grow at a CAGR of 7.3% during 2020–2027. The growth of Asia Pacific medical writing market is driven by increasing number of market players and growing government support in the healthcare sector....
Soluble Guanylate Cyclase - Pipeline Review, H2 2020
Soluble Guanylate Cyclase (sGC or EC 18.104.22.168) pipeline Target constitutes close to 29 molecules. Out of which approximately 26 molecules are developed by companies and remaining by the universities/institutes. The latest report Soluble...
The global API market is forecasted to reach US$270.83 billion in 2024, growing at a CAGR of 6.5% for the period spanning 2020-2024. The factors such as increasing ageing population, rising healthcare expenditure per capita, growing cancer patients, inclining orphan drugs industry and accelerating outsourcing of API drugs are expected to drive...
The global CDMO market is estimated to reach US$241.3 billion in 2024, growing at a CAGR of 9.80% for the period spanning from 2020 to 2024. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.